Spravato™ (esketamine): How do I find out if it’s right for me?
- Call our office and set up a consultation with one of our providers. We’ll discuss your specific circumstances and see if Spravato™ Esketamine may be an option for you.
- What can patients do prior to their psychiatric consultation at the clinic if they are interested in receiving Spravato?
Spravato™ (esketamine): what we know…
- Esketamine, branded as Spravato™ is officially FDA approved for the treatment of treatment resistant depression.
- It is an intra-nasally, self-administered medication.
- It is required to be administered and monitored in an approved clinic, and will require 2 hours of observation in the clinic following each administration.
- The dose will be either 56mg or 84mg depending on the person.
- The course of treatment is twice weekly for 4 weeks, then weekly to every other week indefinitely.
Spravato™ (esketamine): what we don’t know…
- how much it will cost
- which insurances will cover it
- what criteria will need to be met for insurances to cover it
- how it’s effect and efficacy will compare to IV ketamine infusions
Register for the Janssen CarePath Savings Program
The CarePath Savings Program is a rebate program for those with private/commercial health insurance that will reduce the cost per dose to $10 per treatment for up to $7150 worth of treatments. This program does not pay for costs associated with the treatment center fees which may or may not be reimbursable by insurance plans.
Bring a list of your previous psychiatric medications to your consultation, as we will need this to get insurance approval for this medication. Names, doses, length of treatment, and any adverse events will be needed.